MO · 10-Q · 2026Q3 · Full report
Oral Tobacco Revenue and Margins
ALTRIA GROUP, INC. · 2026-10-29 · Importance 72 · Surprise 58 · In source text
For the nine months ended September 30, 2026, oral tobacco net revenues fell 1.2% to $2.070 billion, as a $140 million decline from shipment volume was partly offset by $121 million from higher pricing, including higher promotional investments. Reported operating company income (OCI) declined 10.1% to $1.250 billion; the decrease included $87 million of USSTC Facilities Consolidation costs and $42 million of higher costs. Adjusted OCI fell 4.0% to $1.339 billion, and its margin decreased 2.2 percentage points to 66.8%. For the third quarter, net revenues were essentially unchanged at $[amount not provided in the supplied table], while reported OCI declined 5.4% to $[amount not provided in the supplied table] and adjusted OCI fell 3.7% to $[amount not provided in the supplied table].
Key facts
- For the nine months ended September 30, 2026, reported oral tobacco segment OCI decreased $140 million (10.1%), primarily due to $122 million lower shipment volume, $87 million of 2026 USSTC Facilities Consolidation costs, and $42 million higher costs. source
- Effective August 18, 2026, USSTC raised Copenhagen popular price products, Skoal and Red Seal by $0.10 per can, other Copenhagen brands by $0.12 per can, and Husky by $0.08 per can. source
- Effective August 18, 2026, Helix increased the list price of its on! brand by $0.20 per can. source
- Effective May 12, 2026, USSTC raised list prices on Copenhagen, Skoal and Red Seal by $0.10 per can. source
- Effective March 29, 2026, Helix increased the list price of its on! brand by $0.20 per can. source
- Effective February 17, 2026, USSTC raised list prices on Copenhagen, Skoal and Red Seal by $0.12 per can. source
- For the nine months ended September 30, 2026, oral tobacco segment net revenues decreased $26 million (1.2%) to $2,070 million, primarily due to $140 million lower shipment volume, partly offset by $121 million higher pricing, including higher promotional investments. source
- For the nine months ended September 30, 2026, adjusted oral tobacco segment OCI decreased $56 million (4.0%), primarily due to lower shipment volume and higher costs, partly offset by higher pricing. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | -2.3% | For the nine months ended September 30, 2026, reported oral tobacco segment OCI decreased $140 million (10.1%), primarily due to $122… |